相关实验视频

Updated: Jun 7, 2025

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Published on: July 26, 2018

用于新药发现的2'-化核酸化学:成就和前景

Yonggang Meng^1,2, Nannan Sun², Lan Liang³

¹College of Chemistry, Pingyuan Laboratory, State Key Laboratory of Antiviral Drugs, Zhengzhou University, Zhengzhou 450001, China.

National science review

|November 11, 2024

概括

化核化物在治疗病毒感染和癌症方面显示出显著的治疗前景. 本综述详细介绍了已批准和临床阶段的2'-化核化物,涵盖了它们的发展和未来潜力.

科学领域:

药用化学医学化学
病毒学病毒学
在瘤学瘤学.

背景情况:

化核化物代表了一类经过修改的核化物,具有证明的治疗功效.
几种化核酸被FDA批准或在临床试验中用于治疗病毒感染和癌症.
阿兹丁是一种经批准的化核酸盐,突出了其在治疗COVID-19和HIV方面的潜力.

研究的目的:

在抗病毒和抗瘤疗法中提供2'-化核酸的全面审查.
突出药物发现策略,结构-活性关系和作用机制.
讨论基于核酸的药物发现的挑战和未来方向.

主要方法:

对已确定的和临床阶段的2'-化核化物进行文献综述.
对药物发现策略和结构-活性关系的分析.
检查临床前和临床研究数据.

主要成果:

在市场上和临床阶段的2'-化核化物用于抗病毒和抗癌应用的概述.
详细了解它们的治疗潜力,机制和发展途径.
确定关键的挑战和未来的研究途径.

结论:

2'-化核化物是病毒性和瘤性疾病的有前途的治疗类.
对药物发现,SAR和临床研究的持续研究将推动基于核酸的疗法.
应对当前的挑战对于未来在这个领域的药物开发至关重要.

关键词:

它具有抗瘤活性.抗病毒活动的抗病毒活性.发现药物的发现.化核化物化核化物

更多相关视频

Nucleoside Triphosphates - From Synthesis to Biochemical Characterization

Nucleoside Triphosphates - From Synthesis to Biochemical Characterization

Published on: April 3, 2014

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...